AmirKhandaniMD
Nuclear Medicine • Chapel Hill, NCProfessor, Radiology, University of North Carolina at Chapel Hill School of Medicine
Dr. Khandani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 919-966-1234Fax+1 919-843-5515
Education & Training
Medizinische Fakultät Universität zu KölnClass of 1992
Certifications & Licensure
NC State Medical License 2003 - 2025- American Board of Nuclear Medicine Nuclear Medicine
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer Start of enrollment: 2005 Jul 01
- Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer Start of enrollment: 2009 May 01
- PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study Start of enrollment: 2012 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- FDG PET in a Patient on a GLP-1 Agonist/Insulin Secretagogue.Jorge D Oldan, Paula G Landman, Jennifer A Schroeder, Amir H Khandani, Lilja B Solnes
Clinical Nuclear Medicine. 2024-09-01 - 3 citationsPET/Computed Tomography Transformation of Oncology: Kidney and Urinary Tract Cancers.Jorge D Oldan, Jennifer A Schroeder, Jean Hoffman-Censits, W Kimryn Rathmell, Matthew I Milowsky
PET Clinics. 2024-04-01 - One institutions' experience with a true standard 15 mCi dose of I-131 for the treatment of Graves' disease.Mitchel A Muhleman, Ali Fahim, Thad Benefield, Jorge D Oldan, Amir H Khandani
Nuclear Medicine Communications. 2023-01-01
Press Mentions
Theranostics with RAI Offer a Precision Approach to Treating Differentiated Thyroid CancerJuly 29th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
